Key points are not available for this paper at this time.
-resistant lines are being used to test the "resistance-breaking" efficacy of active compounds early in their development.
Adolfi et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: